HomeAboutFaculty DirectoryLIM Chien Wei John

LIM Chien Wei John


  • NUS Saw Swee Hock School of Public Health (Joint)
  • Executive Director, Centre of Regulatory Excellence, Duke-NUS Graduate Medical School (Primary)
  • Senior Advisor, Ministry of Health, Singapore
  • Chairman, Singapore Clinical Research Institute

Research Areas:

  • Health Regulation/Regulatory Science

Teaching Areas:

  • Health Regulation/Regulatory Science
  • Health Administration

Academic/Professional Qualifications:

  • MBBS (Singapore)
  • M Sc (Public Health) (Singapore)
  • SM (Health Policy & Management) (Harvard)
  • AM (Singapore)


  • Tye Cho Yook Gold Medal

Career History & Administrative Leadership:

  • Chief Executive Officer, Health Sciences Authority
  • Administrator, Singapore Blood Transfusion Service
  • Special Assistant to PS/DMS, Ministry of Health
  • Deputy Director, Institute of Mental Health
  • Deputy Director of Medical Services (Industry & Research Matters), Ministry of Health
  • Director, Human Resource, Ministry of Health
  • Director, Higher Education & Public Affairs, Ministry of Education
  • Director, Centre for Drug Administration, Health Sciences Authority
  • Deputy Chief Executive Officer, Health Sciences Authority

Selected Publications:

  • Lim JCW, Chan CL, Green A. Global Challenges in Regulatory Capacity and Capability Building: Extrapolating Lessons Learned From the HSA. Clinical Pharmacology & Therapeutics. 2018, Advance on line publication, November 20, 2018. DOI: 10.1002/cpt.1253
  • Roth L, et al. Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems. Globalization and Health, Open 2018, 14:102. DOI:10.1186/s12992-018-0421-2.
  • Chong SSF, Lim JCW, Tominaga T. Developing key performance indicators to measure the progress of regional regulatory convergence and cooperation in Asia-Pacific Economic Co-operation (APEC). American Association of Pharmaceutical Scientists (AAPS) Open 2018, 4:4. DOI:10.1186/s41120-018-0024-2.
  • Lim JCW. Strengthening Health Products Regulatory Systems to Enhance Access to Quality Health Products in the Asia-Pacific. Therapeutic Innovation & Regulatory Science 2018, Vol. 52(6) 751-754. First published April 12, 2018. DOI: 10.1177/2168479018769285.
  • Baird LG, et al. Accelerated access to innovative medicines for patients in need. Nature, Clinical Pharmacology & Therapeutics. 2014 Nov; 96(5):559-71. DOI: 10.1038/clpt.2014.145. First published July 9, 2014.
  • Eichler HG, et al. Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval. Nature, Clinical Pharmacology & Therapeutics. 2012; 91(3):426–437. DOI: 10.1038/clpt.2011.345

Tel (65) 6601 1670
Email john.lim@duke-nus.edu.sg


Saw Swee Hock School of Public Health
Tahir Foundation Building
National University of Singapore
12 Science Drive 2
Singapore 117549
For all visitors, kindly proceed to Level 10 Reception Area at MD1
Telephone: (65) 6516 4988
Fascimile: (65) 6779 1489

Connect With Us:     

© National University of Singapore. All Rights Reserved.
Legal   Branding guidelines